Skip to main content

Table 5 All grade 3 and 4 adverse events (n = 44)

From: Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival

Adverse event

Grade 3

Grade 4

  
 

N

%

N

%

Anemia

5

11.4

1

2.3

Neutropenia

2

4.5

5

11.4

Thrombocytopenia

4

9.1

6

13.6

Tumor lysis syndrome

2

4.5

1

2.3

Interstitial pneumonitis

1

2.3

0

0

Ileus

1

2.3

0

0

Herpes zoster infections

1

2.3

0

0

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us